We invite you to participate in first PMNET-Forum
event dedicated to precision medicine for oncological patients!
Applications of genomic technologies are disruptive,
so the challenge for healthcare professionals, healthcare providers, as well as
for researchers and in academia in general, is to learn how to best use
precision medicine. All other stakeholders will need to ensure that their own
knowledge continues to evolve, and this will require a greater emphasis on
continual professional training. For example, if politicians and healthcare
organisers are to discharge their tasks responsibly, they will have to take the
need to be informed about all the implications of their decisions seriously.
The event will take place over two days, it will be
dynamic and multidisciplinary and comprised of ten sessions with range of
national and international experts in clinical oncology, molecular diagnostics,
bioinformatics, research, healthcare, research management, and economics.
International clinical experts will share their experience in several areas,
for example paediatric oncology, cancer of unknown primary, the role of
molecular tumour boards, stratification of patients for clinical trials, and
the importance of collaboration. Many patients and professionals expect high
benefits from precision medicine and have a positive attitude towards it.
However, patients and professionals also perceive some risks like lack of
evidence for efficacy of treatments, the availability of the necessary therapy,
and patients’ limited knowledge that makes informed consent more difficult, can
lead to misuse of data and ethical issues.
In this rapidly changing healthcare world,
stakeholders have a responsibility to identify key barriers existing in policy
and governance, to find and test solutions that bridge identified gaps in order
to ease the way to promote research, to synthesise new knowledge and
implement it as part of value-based healthcare.